Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Open Forum Infectious Diseases|June 30, 2021
IL-7 Immunotherapy in a Nonimmunocompromised Patient With Intractable Fungal Wound SepsisIsaiah R Turnbull, Monty B Mazer, Mark H Hoofnagle, et al.
Shock (Augusta, Ga.)|May 16, 2024
TEMPORAL CHANGES IN INNATE AND ADAPTIVE IMMUNITY DURING SEPSIS AS DETERMINED BY ELISPOTJacqueline Unsinger, Dale Osborne, Andrew H Walton, et al.
Shock (Augusta, Ga.)|October 30, 2025
Quantifying Nuance within Sepsis-Associated Immune Suppression toward Diagnostic CertaintyCharles C Caldwell, Robert Maile, Monty B Mazer, et al.
Critical Care Explorations|August 4, 2021
Interleukin-7 Reverses Lymphopenia and Improves T-Cell Function in Coronavirus Disease 2019 Patient With Inborn Error of Toll-Like Receptor 3: A Case ReportMonty B Mazer, Isaiah R Turnbull, Sydney Miles, et al.
Scientific Reports|April 18, 2025
Determining potential immunomodulatory drug efficacy in sepsis using ELISpotAndrew H Walton, Monty B Mazer, Kenneth E Remy, et al.
Journal of Immunological Methods|August 15, 2024
Development and optimization of a diluted whole blood ELISpot assay to test immune functionRicardo F Ungaro, Julie Xu, Tamara A Kucaba, et al.
Critical Care Explorations|March 31, 2021
Severe Acute Respiratory Syndrome-Associated Coronavirus 2 Infection and Organ Dysfunction in the ICU: Opportunities for Translational ResearchPhilip A Verhoef, Sujatha Kannan, Jamie L Sturgill, et al.
Frontiers in Immunology|October 29, 2024
Surviving septic patients endotyped with a functional assay demonstrate active immune responsesAdam D Price, Ellen R Becker, Evan L Barrios, et al.
Medrxiv : the Preprint Server for Health Sciences|September 25, 2023
Adverse Long-Term Outcomes and an Immune Suppressed Endotype in Sepsis Patients with Reduced Interferon-γELISpot: A Multicenter, Prospective Observational StudyEvan A Barrios, Monty B Mazer, Patrick McGonagill, et al.
JCI Insight|December 15, 2023
Adverse outcomes and an immunosuppressed endotype in septic patients with reduced IFN-γ ELISpotEvan L Barrios, Monty B Mazer, Patrick W McGonagill, et al.
Pageof 2